Navigation Links
Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination

DANBURY, Conn., Feb. 16, 2011 /PRNewswire/ -- Cerno Bioscience today announces the successful test installation and operation of a new software product, MassWorks AutoID™, at a major pharmaceutical company near Boston, MA.  By automating the patented MassWorks calibration and formula ID process on the widely available quadrupole MS systems, AutoID makes the 100x improvement in mass accuracy and the unparallel Spectral Accuracy available seamlessly and at all times.  With both accurate mass and high Spectral Accuracy, AutoID allows any user to either confirm a given formula or propose possible formulas in a fully automated fashion without any human intervention or manual operation.

Built on top of its award-winning MassWorks software, AutoID completely removes the manual steps involved in MassWorks, such as the injection of a calibration standard, the user selection of ions and parameters for elemental composition determination, and the report generation/delivery.  For highly automated applications such as Open Access, AutoID not only brings the formula ID capability to non-expert MS users including synthetic organic or medicinal chemists but also reduces the burden of analytical chemists or mass spectrometrists supporting these functions.

Mr. Hongliang (Leo) Xu, Software Development Manager comments: "The AutoID project is our very first effort at taking the modular components from MassWorks to build new and dedicated applications.  We succeeded by completing this first installation in record time and thus paved the way for more exciting new products to come."  Dr. Yongdong Wang, President of Cerno Bioscience adds: "We built MassWorks with expert MS users in mind and have been very successful at marketing it to hundred of these users around the world.  By making the formula ID capability available seamlessly to non-expert users on a quadrupole system, we can realize significant savings in time, effort, and hardware expenditure for our customers.  While we will continue to enhance and maintain MassWorks software as an industry-leading research tool, AutoID represents the start of our endeavor at introducing automated and dedicated new products to address the broader market needs.  Our goal is to make MassWorks calibration technology and Spectral Accuracy available to every MS user."

To learn more about the concept of Spectral Accuracy, see this front cover feature article in Analytical Chemistry (

For more information on Cerno Bioscience, MassWorks, or AutoID, please email, call +1 203-312-1150, or visit  

About Cerno BioscienceCerno is dedicated to the practical application of modern mathematical techniques to Mass Spectrometry for the purpose of improving the quality, accuracy and reliability of MS analysis. These techniques can be used to dramatically improve the amount of information obtainable from and reduce the amount of time required of many MS experiments. Cerno's technologies are proprietary and protected through numerous patents granted and submitted world-wide. For more information on Cerno MS technologies, applications, or products please visit our Web site:

About Cerno Bioscience ProductsCerno Bioscience's MassWorks family of software products performs post-acquisition MS calibration and formula determination through either CLIPS at unit mass resolution or sCLIPS at higher resolution.  It supports all major MS vendor data formats and works with all MS instruments including GC/MS, LC/MS, TOF, qTOF, and FT MS. Cerno Bioscience products are used in major R&D labs for pharmaceuticals, food, beverages, flavors, fragrances, natural products, environmental analysis, forensics, fine chemicals and petrochemicals. For more information, please visit:

Copyright 2011. Cerno Bioscience LLC. All rights reserved. Cerno Bioscience is a registered trademark and MassWorks, CLIPS, and sCLIPS are trademarks of Cerno Bioscience.  Media Contact:Yongdong WangCerno Bioscience+1

SOURCE Cerno Bioscience
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
2. YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
3. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
4. Sangamo BioSciences Announces Fourth Quarter and Full Year 2010 Conference Call and Webcast
5. Centroid Wins a 2-Year Infrastructure Outsourcing Services Contract with eBioscience
6. YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium
7. Ardea Biosciences Prices Public Offering of Common Stock
8. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students
11. YM BioSciences Closes Public Offering of Common Shares
Post Your Comments:
(Date:11/30/2015)... Zenith Epigenetics Corp. ("Zenith" or the "Company") today announced that ... its Board of Directors to replace Dr. Peter Johann ... experience as co-founder of Resverlogix, with expertise in the fields ... --> Dr. Wong remarked, "I am very excited ... standing expertise in epigenetics and the advanced stage of the ...
(Date:11/30/2015)... , Nov. 30, 2015  Champions Oncology, Inc. (CSBR), ... services to personalize the development and use of oncology ... Executive Officer, will be presenting at the LD MICRO ... Pacific Standard Time (PST).  The conference, held at the ... Angeles, CA , will feature 200 small/micro-cap companies ...
(Date:11/30/2015)... 2015  HUYA Bioscience International, the leader in accelerating ... innovations, today announced it has signed a Memorandum of ... foster collaboration between KDDF and HUYA with the ultimate ... products for the global market. ... new innovative preclinical and clinical stage compounds. The company ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December ... (ECNR) in Vienna, Austria to ... wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), ... NovaVision Therapy Suite at the 3rd European Congress of ...
Breaking Biology Technology:
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... JOSE, Calif. , Nov. 9, 2015  Synaptics ... human interface solutions, today announced broader entry into the ... vehicle-specific solutions that match the pace of consumer electronics ... and biometric sensors are ideal for the automotive industry ... vehicle. Europe , ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):